BioSpace News Archive

ADMA Biologics, Inc. an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases, announced that it has commenced an $75 million underwritten public offering of its common stock.

Precision Optics Corporation, Inc. announced that it has scheduled a conference call to discuss second quarter of fiscal 2020 financial results on Thursday, February 13, 2020 at 5:00pm ET.

Exelixis, Inc. announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will be presenting at the following investor conferences in February

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction -based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic development and a developer of liquid biopsies announced consolidated financial results for the fiscal first quarter ended December 31, 2019.

Bioasis Technologies Inc. announced that Dr. Deborah Rathjen, Executive Chair and Chief Executive Officer of Bioasis will present at the following conferences

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, reported financial results and business highlights for the first quarter of fiscal 2020, ended December 31, 2019.

Juvare announced that the company’s solutions were used by state and local agencies for situational awareness and critical incident response to ensure safety in Kansas City, Mo., during the Chiefs’ victory parade and celebration on Wednesday.

Rockwell Medical, Inc. announced that Stuart Paul, Chief Executive Officer, will present at the 2020 BIO CEO & Investor Conference

Onkos Surgical® is pleased to announce the launch of GenVie™ Magnesium Bone Scaffold, a novel biologic technology that further expands Onkos’ reach in complex limb salvage procedures.

Agilent Technologies Inc. announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims against Twist, as well as current and former Twist employees Emily Leproust, Siyuan Chen, and Solange Glaize.